Head-to-Head: which lupus drug works better?
Disease control
Not yet recruiting
This study compares two drugs, telitacicept and belimumab, for controlling systemic lupus erythematosus (SLE) in adults aged 18-65. Participants choose their treatment with their doctor, and researchers track how well each drug reduces lupus activity and kidney problems. The goal…
Sponsor: Yipeng Liu • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC